pharmaphorum5d
FDA approves Adstiladrin as first gene therapy for NMIBC
The US Food and Drug Administration (FDA) has approved Swiss drugmaker Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firedenovec-vncg) for the treatment of adult patients with high-risk ...
The Bakersfield Californian18d
First Real-World Outcomes Data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be Presented at 2025 ASCO Genitourinary Cancers Symposium
Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN ® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists ...
Hosted on MSN10mon
Ferring Pharmaceuticals Partners with SK pharmteco to Boost Gene Therapy Supply
PARSIPPANY, NJ & KING OF PRUSSIA, PA — Ferring Pharmaceuticals has teamed up with SK pharmteco to scale up the commercial manufacturing capacity of ADSTILADRIN (nadofaragene firadenovec-vncg), a ...
First Real-World Outcomes Data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be Presented at 2025 ASCO Genitourinary Cancers Symposium
First real-world outcomes data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be presented at 2025 ASCO Genitourinary Cancers Symposium ...